Evaluation of Abnormal Liver Chemistries
Recommendations
Recommendation Grading
Overview
Title
Evaluation of Abnormal Liver Chemistries
Authoring Organization
American College of Gastroenterology
Publication Month/Year
January 1, 2017
Last Updated Month/Year
April 2, 2024
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
These recommendations are intended for use by physicians and health care providers and suggest preferred approaches to the diagnoses and evaluation of those with abnormal liver tests
Target Patient Population
Patients with abnormal liver function tests
Inclusion Criteria
Female, Male, Adolescent, Adult, Child, Older adult
Health Care Settings
Ambulatory, Home health, Hospital, Long term care, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Assessment and screening, Diagnosis, Management
Diseases/Conditions (MeSH)
D008107 - Liver Diseases, D008099 - Liver, D000410 - Alanine Transaminase, D001219 - Aspartate Aminotransferases, D008111 - Liver Function Tests
Keywords
liver function, liver chemistry, alanine transaminase
Source Citation
Kwo, Paul Y MD, FACG, FAASLD; Cohen, Stanley M MD, FACG, FAASLD; Lim, Joseph K MD, FACG, FAASLD. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries, American Journal of Gastroenterology: January 2017 - Volume 112 - Issue 1 - p 18-35 doi: 10.1038/ajg.2016.517